Mindbytes Jul 15, 2026
DNA-Shredding CRISPR Enzyme Takes Aim at Cancer Cells, Including "Undruggable" Tumors
Scientists designed CRISPR to self-destruct tumor cells carrying p53 mutations, a target no drug has ever reached. A Nature paper details the approach for ovarian, pancreatic, and lung cancers.
Linsey